Humulin 70/30 KwikPen 100 [iU]/mL
Insulin human · INJECTION, SUSPENSION · Eli Lilly and Company
No Recall HistoryCurrently in Shortage
Plain English
Humulin 70/30 KwikPen is a injection, suspension containing insulin human at 100 [iU]/mL, taken subcutaneous. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Humulin 70/30 KwikPen
- Generic Name
- Insulin human
- NDC Code (Product)
0002-8803- Manufacturer
- Eli Lilly and Company
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA019717
- Drug Class
- Insulin [EPC]
- Marketing Start
- 11/07/2013
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
blood glucose increased1,012 reports
hypoglycaemia423 reports
drug ineffective385 reports
dyspnoea366 reports
diarrhoea346 reports
blood glucose decreased314 reports
hyperglycaemia310 reports
nausea301 reports
off label use275 reports
headache272 reports
Frequently Asked Questions
What is Humulin 70/30 KwikPen used for?
Humulin 70/30 KwikPen contains Insulin human. It is a injection, suspension taken subcutaneous. Consult your doctor for specific uses.
Is Humulin 70/30 KwikPen a controlled substance?
Humulin 70/30 KwikPen is not classified as a controlled substance by the DEA.
What is the generic name for Humulin 70/30 KwikPen?
The generic name for Humulin 70/30 KwikPen is Insulin human. There are 11 other brand versions of Insulin human.
What is the NDC code for Humulin 70/30 KwikPen 100 [iU]/mL?
The NDC (National Drug Code) for Humulin 70/30 KwikPen 100 [iU]/mL is 0002-8803, listed by Eli Lilly and Company.